台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    101.0
  • 漲跌
    ▲0.5
  • 漲幅
    +0.50%
  • 成交量
    25
  • 產業
    上櫃 文化創意指數▲0.81%
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-元大-內湖民權 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-內湖民權 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/06/1100.002102.00101.50-2156-1.28%
2024/06/0400.002102.25103.00-2158-1.26%
2024/05/202103.0100.00103.5021541.30%
2024/05/170105.5000.00105.5001520.00%
2024/05/1500.002103.00104.00-2148-1.35%
2024/05/142101.5000.00102.0021441.38%
2024/05/130107.0000.00107.0001270.00%
2024/05/070119.0000.00119.5001190.01%
2024/05/060119.5000.00119.0001180.00%
2024/05/030118.5000.00118.5001170.00%
2024/04/0200.000.1123.42123.50-0.170-0.09%
2024/03/290122.0000.00122.000680.01%
2024/03/2800.001122.00122.50-167-1.49%
2024/03/270.1122.0000.00122.000.1660.08%
2024/03/260124.5000.00123.000630.02%
2024/03/1800.001122.50124.00-151-1.95%
2024/03/141.1118.592119.00119.00-0.943-2.08%
2024/03/1200.002116.00117.00-238-5.15%
2024/03/1100.001114.50114.50-136-2.77%
2024/03/0500.000.1113.00113.50-0.133-0.30%
2024/02/260.1112.5000.00112.000.1320.15%
2024/02/1900.000112.00113.00031-0.04%
2024/02/020111.500111.69112.00031-0.03%
2024/01/300110.000110.00110.00031-0.02%
2024/01/260111.000111.00110.50030-0.02%
2024/01/240111.000111.00110.500300.00%
2024/01/230111.5000.00111.000290.03%
2024/01/220111.5000.00111.500290.03%
2024/01/180111.5000.00111.000290.06%
2024/01/1600.000.1112.50112.50-0.129-0.23%
2024/01/1500.000113.00112.50029-0.11%
2024/01/111111.5000.00111.501293.42%
2024/01/100.1111.0000.00111.000.1280.35%
2023/12/2900.000.1115.50115.00-0.124-0.20%
2023/12/110.1114.0000.00113.500.1210.23%
2023/11/280114.5000.00114.000200.03%
2023/11/070116.0000.00115.500190.03%
2023/11/020115.5000.00115.000200.05%
2023/10/230117.000117.00117.000220.03%
2023/10/130117.5000.00117.000250.02%
2023/10/040115.500115.50116.00025-0.01%
2023/09/280114.000114.00114.00025-0.01%
2023/09/193114.5000.00114.0032611.21%
2023/09/0100.000.1112.00111.50-0.129-0.27%
2023/08/021111.0000.00111.001333.02%
2023/07/280115.0000.00115.000320.02%
2023/07/171108.5000.00108.001293.34%
2023/07/131108.5000.00108.001313.22%
2023/07/100109.0000.00108.500390.03%
2023/05/100108.0000.00107.000550.01%
2023/05/091106.5000.00107.001551.81%
2023/04/251109.0000.00109.001521.89%
2023/03/1700.001113.00112.00-126-3.77%
2023/03/081115.5000.00116.001342.86%
2023/01/0500.000108.00108.50039-0.01%
2022/11/0300.001100.50101.00-119-5.24%
2022/10/31199.5000.0099.201175.66%
2022/10/2100.001101.00100.00-115-6.42%
2022/10/191100.0000.00101.001156.33%
2022/10/110104.5000.00104.000160.02%
2022/09/290106.0000.00106.000160.01%
2022/06/2000.00099.0098.70045-0.06%
2022/06/1500.000101.0099.50046-0.09%
2022/05/1900.00197.6097.90-144-2.27%
2022/05/18199.0000.0097.901432.30%
2022/05/1600.00199.5398.70-141-2.45%
2022/05/131104.0000.00102.501402.50%
2022/04/261122.5000.00122.001253.90%
2022/03/290.1134.0000.00133.500.1200.40%
2022/02/2100.000.1126.50126.50-0.121-0.26%
2022/01/1000.001.3126.14125.50-1.323-5.36%
2021/10/270.6129.0000.00128.000.6371.61%
2021/10/260.3129.0000.00128.000.3380.68%
2021/09/080142.000.2143.00141.00-0.234-0.56%
2021/08/1100.004149.00149.50-435-11.18%
2021/03/0900.003.5130.50130.50-3.527-12.70%
2021/03/0800.001130.00129.50-127-3.59%
2021/03/052130.0000.00131.002277.33%
2021/03/022129.5000.00128.002267.54%
2020/11/263120.0000.00120.003319.44%
2020/11/2500.001120.00120.50-132-3.06%
2020/08/311114.5000.00114.001581.72%
2020/06/290.9107.5000.00107.500.9621.45%
2020/06/240.1116.0000.00116.000.1590.17%
2020/06/2300.001114.50115.00-157-1.75%
2020/04/130.999.1000.0099.200.9422.11%
2020/03/0600.002100.50101.00-226-7.55%
2020/03/0200.001100.50100.50-126-3.73%
2020/02/0600.001.2101.33101.50-1.227-4.37%
2020/02/0500.001100.50100.50-127-3.61%
2020/02/03099.0000.0099.800270.07%
2020/01/071101.5000.00102.001234.18%
2020/01/061102.0000.00101.501234.32%
2020/01/032102.0000.00102.002229.03%
2019/12/0200.001101.50101.50-120-4.80%
2019/10/300101.0000.00101.500210.07%
2019/07/090101.5000.00101.000450.04%
2019/04/151109.0000.00109.501372.69%
2019/02/2500.002109.50110.00-223-8.35%
2019/02/192109.0000.00108.502229.03%
2018/12/210102.0000.00102.000270.06%
2018/11/060106.0000.00106.000290.05%
2018/10/090.8101.5000.00101.500.8431.84%
2018/07/252126.0000.00127.002872.29%
2018/07/0400.001121.00122.00-187-1.15%
2018/05/2100.002125.00124.50-2127-1.57%
2018/05/1800.005125.00125.00-5128-3.90%
2018/05/1400.000126.00126.000131-0.01%
2018/05/113125.0000.00124.5031302.30%
2018/05/0700.006130.67131.50-6124-4.82%
2018/05/0400.001130.00128.50-1117-0.85%
2018/05/032130.003130.00129.00-1116-0.85%
2018/04/1600.000125.00125.0001620.00%
2018/04/102126.0000.00126.0021641.21%
2018/04/0200.002130.50129.50-2162-1.23%
2018/03/3100.001129.50129.50-1160-0.62%
2018/03/290126.5000.00128.5001610.00%
2018/03/2300.001124.00124.00-1166-0.60%
2018/03/222127.0000.00125.5021701.17%
2018/03/212129.751128.50128.5011830.54%
2018/03/191127.0000.00127.5011760.57%
2018/03/1500.001122.00122.50-1168-0.59%
2018/03/0900.002119.50120.00-2172-1.16%
2018/02/2300.002118.00117.00-2169-1.18%
2018/02/122113.2500.00113.5021671.19%
2018/02/095114.6000.00116.0051663.00%
2018/02/064114.1300.00112.0041652.42%
2018/02/052120.5000.00122.0021631.23%
2018/02/011119.0000.00120.0011630.61%
2018/01/2900.004121.50123.00-4162-2.47%
2018/01/2500.001124.49123.50-1161-0.63%
2018/01/223123.8300.00122.5031521.97%
2018/01/1910129.003126.50124.0071484.72%
2018/01/181121.5000.00121.5011340.74%
2018/01/1700.006121.08121.50-6129-4.63%
2018/01/162117.251118.50116.0011180.84%
2018/01/150117.0010115.60118.00-10114-8.70%
2018/01/112109.0000.00110.0021041.92%
2018/01/0500.004114.25112.00-499-4.01%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音